Study Finds the Corus® CAD Gene Expression Blood Test Influenced Primary Care Decision- Making in the Assessment of Patients with Suspected Obstructive Coronary Artery Disease by longitudeadmin | Mar 10, 2014 | Portfolio News
Allergen Research Corporation Initiates Phase 2b Clinical Trial for Peanut Allergy Oral Immunotherapy (OIT) by longitudeadmin | Feb 27, 2014 | Portfolio News
The Corus CAD Gene Expression Test Can Help Commercial Health Plans Reduce Costs by Improving the Accuracy of the Diagnostic Workup in Patients with Suspected Obstructive Coronary Artery Disease by longitudeadmin | Feb 26, 2014 | Portfolio News
Amarin Announces FDA Award of Three-Year Exclusivity for Vascepa® (icosapent ethyl) Capsules by longitudeadmin | Feb 21, 2014 | Portfolio News
Jazz Pharmaceuticals Announces U.S. Commercial Availability Of Versacloz™ (clozapine, USP) Oral Suspension by longitudeadmin | Feb 11, 2014 | Portfolio News
